Article
Author(s):
Seattle-A retrospective review of patients with secondary azoospermia has uncovered an alarming tumor rate and a high sperm recovery rate, reiterating the importance of urologic evaluation in this population.
Addressing an unmet need: CELLEBRATE trial explores cell-based therapy for recurrent SUI
Pearls & Perspectives: Understanding and Improving Pelvic Health, with Diane Newman, DNP
Vaginal prolapse repair and sling surgery significantly reduce UUI
Pearls & Perspectives: Advancing sexual health in urology, with Rachel Rubin, MD, at AUA 2025
FDA grants marketing authorization to at-home diagnostic test for STIs
Expert discusses unique mechanism of action of UTI treatment gepotidacin
Sintilimab plus fruquintinib under review in China for advanced renal cell carcinoma
Data supports mitomycin plus BCG as alternative to BCG alone in NMIBC
Zanzalintinib plus nivolumab shows safety, efficacy for stage 4 RCC
GLP-1 agonist use is rising in men with prostate cancer